{"id":"W2265121903","doi":"10.1007/s10637-016-0324-0","title":"A phase II study of cediranib, an oral VEGF inhibitor, in previously untreated patients with metastatic or recurrent malignant melanoma","year":2016,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Health Sciences Centre; Ontario Clinical Oncology Group; Juravinski Cancer Centre; Princess Margaret Cancer Centre; Hamilton Health Sciences","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Medicine; Nausea; Internal medicine; Progressive disease; Melanoma; Adverse effect; Gastroenterology; Phases of clinical research; Response Evaluation Criteria in Solid Tumors; Oncology; Toxicity; Chemotherapy; Surgery; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001429231,0.001287518,0.002851775,0.0004451703,0.0005216651,0.0009441022,0.0008103742,0.001127123,0.002137832],"category_scores_gemma":[0.0009223146,0.0006351198,0.001544793,0.0003838772,0.0009131925,0.0006708595,0.0002573188,0.002977279,0.0005734261],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008550208,"about_ca_system_score_gemma":0.001233049,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002137044,"about_ca_topic_score_gemma":0.005294906,"domain_scores_codex":[0.9995847,0.0001947042,0.00001688866,0.00006524861,0.00003607951,0.0001023225],"domain_scores_gemma":[0.9993613,0.0001197291,0.00008449175,0.00006385105,0.00003322528,0.0003373407],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7179797,0.06643746,0.01356006,0.00104321,0.003039366,0.0007653118,0.0005015765,0.00346812,0.07973911,0.0004630214,0.003733934,0.1092692],"study_design_scores_gemma":[0.5351472,0.4349973,0.01932085,0.00003569509,0.0009793811,0.0005524519,0.000102237,0.001333569,0.00364813,0.000171077,0.003668637,0.00004335482],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923091,0.003380069,0.0005040913,0.0003971899,0.0001650932,0.001079431,0.000537573,0.00005419729,0.001573182],"genre_scores_gemma":[0.98962,0.003241508,0.001261879,0.0007225273,0.0002053497,0.001075166,0.001446701,0.0000304161,0.002396364],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002851775,"threshold_uncertainty_score":0.007558584,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02402729017134401,"score_gpt":0.2711577410912109,"score_spread":0.2471304509198669,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}